SEC Form 4 · accession 0001144204-18-064722
Ra Pharmaceuticals, Inc. · RARX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
RA Capital Healthcare Fund LP
Director · 10% Owner
RA CAPITAL MANAGEMENT, LLC
Director · 10% Owner
Peter Kolchinsky
Director · 10% Owner
Period of report
Dec 14, 2018
Accepted (ET)
Dec 14, 2018 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001481512
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 12, 2018 | P | 1,006,452 | $15.50 | A | 4,858,260 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These securities include 836,666 shares held by RA Capital Healthcare Fund, L.P. (the "Fund") and 169,786shares held in an account owned by a separately managed account (the "Account").
- F2Represents 3,971,750 shares of Common Stock held by the Fund and 886,510 shares of Common Stock held in the Account.
- F3RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Peter Kolchinsky is the sole manager of the Adviser. The Adviser and Dr. Kolchinsky disclaim beneficial ownership of the reported securities in reliance on Rule 16a-1(a)(1)(v) and (vii) and disclaim any obligation to file reports under Section 16 other than as directors by deputization. The Adviser and Dr. Kolchinsky have no pecuniary interest in the reported securities held in the Account and disclaim: (A) beneficial ownership thereof for purposes of Rule 16a-1(a)(2) and (B) beneficial ownership of securities held by the Fund, for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein.